2024 Rome, Italy

III-01 Lisa Amann
Stepwise Covariate Modelling (SCM) versus Full Random Effects Modelling (FREM) for covariate modelling of correlated covariates exemplified with tigecycline and liver function markers
III-02 Kyle Baron
Development and validation of open-source pharmacometrics software using an iterative software development life cycle methodology: the pmtables R package for submission-ready table generation.
III-03 Julie Bertrand
Model-based approaches for bioequivalence studies with only one-time point measured drug concentration
III-04 Sabrina Boutaghou
On the influence of sampling schemes on the demonstration of bioequivalence
III-05 Núria Buil Bruna
Cheat sheet for pharmacometrics communication
III-06 Jung-woo CHAE
The effect of CYP2D6 phenotypes on the pharmacokinetics of propafenone: a systematic review and meta-analysis
III-07 Estelle Chasseloup
Individual Model Averaging to increase robustness in drug effect estimation
III-08 Chao Chen
Translational modelling and estimation of probability of molecule success on balance of pharmacology benefit and safety risk
III-09 David Cristinacce
PoPy: Population PKPD Analysis in Python
III-10 David Fairman
Towards Industrialisation of Probability of Pharmacological Success (PoPS)
III-11 Manu Francis
Subspace MCMC algorithm for Bayesian parameter estimation of hierarchical PK/PD models in Pumas
III-12 Leonid Gibiansky
Calibration of an IgG turnover model using data from administration of monoclonal antibodies targeting FcRn receptor
III-13 Jan Grzegorzewski
PK-DB: pharmacokinetics database for individualized and stratified computational modeling
III-14 Benjamin Guiastrennec
Improving the reproducibility of NONMEM-based pharmacometric analyses
III-15 Woojin Jung
Web based platform for clinical pharmacokinetic consultation service (CPCS) with Non-linear Mixed Effect Model
III-16 Lina Keutzer
Machine learning for covariate selection and prediction of pharmacokinetic data illustrated with rifampicin
III-17 Niklas Korsbo
Latexify.jl - An ecosystem for automatically transcribing Pumas and Julia objects into renderable equations.
III-18 Anne Kümmel
IQnca: An open-source R package for efficient and reproducible non-compartmental analysis in R
III-19 Silvia Maria Lavezzi
Evaluation of efficacy predictors and probability of pharmacological success for a novel compound to treat parasitic disease proposed for first-time-into-human
III-20 Félicien Le Louedec
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr
III-21 Christopher Rackauckas
Automated Machine Learning Acceleration of Pharmacometrics Models in Pumas with JuliaSim 
III-22 Thi Quyen Tran
Overview of Korean Pharmacometrics Modeling Library and web-based pharmacometrics platform
III-23 Anastasia Tsyplakova
Development and validation of a population pharmacokinetic model for donepezil
III-24 Lisa van der Heijden
Extrapolation of Phase 0 microdosing trials: a naïve pooled data modelling approach.
III-25 Zhengguo Xu
Estimators and Confidence Intervals of f2 Using Bootstrap Methodology for the Comparison of Dissolution Profiles
III-26 Simone Zannoni
Investigating the identifiability of one-stage IVIVC population models for extended-release dosage forms